293 related articles for article (PubMed ID: 17538177)
1. Increased permeability of the blood-brain barrier to chemotherapy in metastatic brain tumors: establishing a treatment paradigm.
Gerstner ER; Fine RL
J Clin Oncol; 2007 Jun; 25(16):2306-12. PubMed ID: 17538177
[TBL] [Abstract][Full Text] [Related]
2. Response of brain specific microenvironment to P-glycoprotein inhibitor: an important factor determining therapeutic effect of P-glycoprotein inhibitor on brain metastatic tumors.
Joo KM; Song SY; Park K; Kim MH; Jin J; Kang BG; Jang MJ; Lee GS; Kim MS; Nam DH
Int J Oncol; 2008 Oct; 33(4):705-12. PubMed ID: 18813783
[TBL] [Abstract][Full Text] [Related]
3. Modulation of the blood-brain barrier in oncology: therapeutic opportunities for the treatment of brain tumours?
Kemper EM; Boogerd W; Thuis I; Beijnen JH; van Tellingen O
Cancer Treat Rev; 2004 Aug; 30(5):415-23. PubMed ID: 15245774
[TBL] [Abstract][Full Text] [Related]
4. Randomized study of paclitaxel and tamoxifen deposition into human brain tumors: implications for the treatment of metastatic brain tumors.
Fine RL; Chen J; Balmaceda C; Bruce JN; Huang M; Desai M; Sisti MB; McKhann GM; Goodman RR; Bertino JS; Nafziger AN; Fetell MR
Clin Cancer Res; 2006 Oct; 12(19):5770-6. PubMed ID: 17020983
[TBL] [Abstract][Full Text] [Related]
5. [Pharmacologic bases of chemotherapy of brain tumors in children].
Vassal G
Bull Cancer; 1990; 77(7):699-713. PubMed ID: 2207360
[TBL] [Abstract][Full Text] [Related]
6. Paclitaxel nanoparticles for the potential treatment of brain tumors.
Koziara JM; Lockman PR; Allen DD; Mumper RJ
J Control Release; 2004 Sep; 99(2):259-69. PubMed ID: 15380635
[TBL] [Abstract][Full Text] [Related]
7. Chemotherapy delivery issues in central nervous system malignancy: a reality check.
Muldoon LL; Soussain C; Jahnke K; Johanson C; Siegal T; Smith QR; Hall WA; Hynynen K; Senter PD; Peereboom DM; Neuwelt EA
J Clin Oncol; 2007 Jun; 25(16):2295-305. PubMed ID: 17538176
[TBL] [Abstract][Full Text] [Related]
8. Blood-brain barrier and chemotherapeutic treatment of brain tumors.
de Vries NA; Beijnen JH; Boogerd W; van Tellingen O
Expert Rev Neurother; 2006 Aug; 6(8):1199-209. PubMed ID: 16893347
[TBL] [Abstract][Full Text] [Related]
9. Increased delivery of erucylphosphocholine to C6 gliomas by chemical opening of the blood-brain barrier using intracarotid pentylglycerol in rats.
Erdlenbruch B; Jendrossek V; Kugler W; Eibl H; Lakomek M
Cancer Chemother Pharmacol; 2002 Oct; 50(4):299-304. PubMed ID: 12357304
[TBL] [Abstract][Full Text] [Related]
10. The blood-brain barrier and cancer: transporters, treatment, and Trojan horses.
Deeken JF; Löscher W
Clin Cancer Res; 2007 Mar; 13(6):1663-74. PubMed ID: 17363519
[TBL] [Abstract][Full Text] [Related]
11. Changes in blood-brain barrier permeability induced by radiotherapy: implications for timing of chemotherapy? (Review).
van Vulpen M; Kal HB; Taphoorn MJ; El-Sharouni SY
Oncol Rep; 2002; 9(4):683-8. PubMed ID: 12066192
[TBL] [Abstract][Full Text] [Related]
12. The effect of P-glycoprotein on paclitaxel brain and brain tumor distribution in mice.
Gallo JM; Li S; Guo P; Reed K; Ma J
Cancer Res; 2003 Aug; 63(16):5114-7. PubMed ID: 12941842
[TBL] [Abstract][Full Text] [Related]
13. Targeted delivery in primary and metastatic brain tumors: summary report of the seventh annual meeting of the Blood-Brain Barrier Disruption Consortium.
Doolittle ND; Abrey LE; Ferrari N; Hall WA; Laws ER; McLendon RE; Muldoon LL; Peereboom D; Peterson DR; Reynolds CP; Senter P; Neuwelt EA
Clin Cancer Res; 2002 Jun; 8(6):1702-9. PubMed ID: 12060607
[TBL] [Abstract][Full Text] [Related]
14. [Chemotherapy of brain tumors: biological basis of its limited efficacy].
Mousseau M
Bull Cancer; 1994 May; 81(5):414-24. PubMed ID: 7749219
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of P-glycoprotein activity at the primate blood-brain barrier increases the distribution of nelfinavir into the brain but not into the cerebrospinal fluid.
Kaddoumi A; Choi SU; Kinman L; Whittington D; Tsai CC; Ho RJ; Anderson BD; Unadkat JD
Drug Metab Dispos; 2007 Sep; 35(9):1459-62. PubMed ID: 17591677
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetic profile of the microtubule stabilizer patupilone in tumor-bearing rodents and comparison of anti-cancer activity with other MTS in vitro and in vivo.
O'Reilly T; Wartmann M; Brueggen J; Allegrini PR; Floersheimer A; Maira M; McSheehy PM
Cancer Chemother Pharmacol; 2008 Nov; 62(6):1045-54. PubMed ID: 18301895
[TBL] [Abstract][Full Text] [Related]
17. Progress in brain penetration evaluation in drug discovery and development.
Liu X; Chen C; Smith BJ
J Pharmacol Exp Ther; 2008 May; 325(2):349-56. PubMed ID: 18203948
[TBL] [Abstract][Full Text] [Related]
18. Fetal blood-brain barrier P-glycoprotein contributes to brain protection during human development.
Virgintino D; Errede M; Girolamo F; Capobianco C; Robertson D; Vimercati A; Serio G; Di Benedetto A; Yonekawa Y; Frei K; Roncali L
J Neuropathol Exp Neurol; 2008 Jan; 67(1):50-61. PubMed ID: 18091560
[TBL] [Abstract][Full Text] [Related]
19. Osmotic blood-brain barrier modification for the treatment of malignant brain tumors.
Haluska M; Anthony ML
Clin J Oncol Nurs; 2004 Jun; 8(3):263-7. PubMed ID: 15208820
[TBL] [Abstract][Full Text] [Related]
20. A review on the impact of P-glycoprotein on the penetration of drugs into the brain. Focus on psychotropic drugs.
Linnet K; Ejsing TB
Eur Neuropsychopharmacol; 2008 Mar; 18(3):157-69. PubMed ID: 17683917
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]